Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancer.
Breast cancer recurrence and mortality among survivors of childhood cancer.
Racialized inequities in live birth after cancer: A population-based study of 63,000 female adolescents and young adults with cancer.
Colorectal Cancer Screening Receipt Does Not Differ by 10-Year Mortality Risk Among Older Adults.
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer.
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer. Am Soc Clin Oncol Educ Book. 2026 Jun; 46(3):e520834.
View in:
PubMed
subject areas
Biomarkers, Tumor
Female
Humans
Neoadjuvant Therapy
Neoplasm Staging
Precision Medicine
Triple Negative Breast Neoplasms
authors with profiles
Rita Nanda